Oncopeptides AB (publ) (FRA:OND)
0.5000
+0.0440 (9.65%)
At close: Nov 28, 2025
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of €134.15 million as of December 1, 2025. Its market cap has increased by 370.26% in one year.
Market Cap
134.15M
Enterprise Value
134.23M
Revenue
5.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.50
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 176.17M to 134.15M, a decrease of -23.85%. That is a compound annual growth rate of -3.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 144.36M | 394.09% |
| Dec 30, 2024 | 29.22M | -55.05% |
| Dec 29, 2023 | 65.00M | -36.80% |
| Dec 30, 2022 | 102.86M | 66.56% |
| Dec 30, 2021 | 61.75M | -94.61% |
| Dec 30, 2020 | 1.14B | 70.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |